Korean J Dermatol.  2010 Feb;48(2):143-147.

Nephrogenic Fibrosing Dermopathy Improved after Renal Transplantation

Affiliations
  • 1Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea. drkmp@hanmail.net
  • 2Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Korea.

Abstract

Nephrogenic fibrosing dermopathy (NFD) is a rare cutaneous fibrosing disorder that primarily affects patients with a history of renal disease. NFD manifests with induration, thickening and hardening of the skin with brawny hyperpigmentation. Lesions are typically symmetrical and usually develop on the limbs and trunk. Flexion contractures of the joints may be a feature of the disease. Histopathological features of NFD include proliferation of dermal fibroblasts and dendritic cells, thickened collagen bundles, increased elastic fibers and focal mucin deposition. Although the pathogenesis remains largely unknown, some of the factors implicated in the pathogenesis include renal dysfunction, circulating fibrocytes, vascular injury, and gadolinium which is a contrast material used in magnetic resonance imaging. Currently, no definitive or uniformly effective therapies are available for the treatment of NFD. We herein describe the case of a 44-year-old female NFD patient who undergoes significant improvement of skin lesions and associated joint contracture after renal transplantation.

Keyword

Nephrogenic fibrosing dermopathy; Renal dysfunction; Renal transplantation

MeSH Terms

Adult
Carubicin
Collagen
Contracture
Dendritic Cells
Elastic Tissue
Extremities
Female
Fibroblasts
Gadolinium
Humans
Hyperpigmentation
Joints
Kidney Transplantation
Magnetic Resonance Imaging
Mucins
Nephrogenic Fibrosing Dermopathy
Skin
Vascular System Injuries
Carubicin
Collagen
Gadolinium
Mucins
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr